158 related articles for article (PubMed ID: 34628621)
1. Relationship between Papillomavirus vaccine, vaginal microbiome, and local cytokine response: an exploratory research.
Giraldo PC; Sanches JM; Sparvolli LG; Amaral R; Migliorini I; Gil CD; Taddei CR; Witkin SS; Discacciati MG
Braz J Microbiol; 2021 Dec; 52(4):2363-2371. PubMed ID: 34628621
[TBL] [Abstract][Full Text] [Related]
2. Cervical Squamous Intraepithelial Lesions Are Associated with Differences in the Vaginal Microbiota of Mexican Women.
Nieves-Ramírez ME; Partida-Rodríguez O; Moran P; Serrano-Vázquez A; Pérez-Juárez H; Pérez-Rodríguez ME; Arrieta MC; Ximénez-García C; Finlay BB
Microbiol Spectr; 2021 Oct; 9(2):e0014321. PubMed ID: 34643408
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory cytokines and a diverse cervicovaginal microbiota associate with cervical dysplasia in a cohort of Hispanics living in Puerto Rico.
Tosado-Rodríguez E; Mendez LB; Espino AM; Dorta-Estremera S; Aquino EE; Romaguera J; Godoy-Vitorino F
PLoS One; 2023; 18(12):e0284673. PubMed ID: 38064478
[TBL] [Abstract][Full Text] [Related]
4. Correlation between the diversity of vaginal microbiota and the risk of high-risk human papillomavirus infection.
Chao XP; Sun TT; Wang S; Fan QB; Shi HH; Zhu L; Lang JH
Int J Gynecol Cancer; 2019 Jan; 29(1):28-34. PubMed ID: 30640680
[TBL] [Abstract][Full Text] [Related]
5. Microbiota and HPV: The role of viral infection on vaginal microbiota.
Santella B; Schettino MT; Franci G; De Franciscis P; Colacurci N; Schiattarella A; Galdiero M
J Med Virol; 2022 Sep; 94(9):4478-4484. PubMed ID: 35527233
[TBL] [Abstract][Full Text] [Related]
6. Effects of varying antigens and adjuvant systems on the immunogenicity and safety of investigational tetravalent human oncogenic papillomavirus vaccines: results from two randomized trials.
Van Damme P; Leroux-Roels G; Simon P; Foidart JM; Donders G; Hoppenbrouwers K; Levin M; Tibaldi F; Poncelet S; Moris P; Dessy F; Giannini SL; Descamps D; Dubin G
Vaccine; 2014 Jun; 32(29):3694-705. PubMed ID: 24674663
[TBL] [Abstract][Full Text] [Related]
7. Relationship between vaginal and oral microbiome in patients of human papillomavirus (HPV) infection and cervical cancer.
Zhang W; Yin Y; Jiang Y; Yang Y; Wang W; Wang X; Ge Y; Liu B; Yao L
J Transl Med; 2024 Apr; 22(1):396. PubMed ID: 38685022
[TBL] [Abstract][Full Text] [Related]
8. Ten-year immune persistence and safety of the HPV-16/18 AS04-adjuvanted vaccine in females vaccinated at 15-55 years of age.
Schwarz TF; Galaj A; Spaczynski M; Wysocki J; Kaufmann AM; Poncelet S; Suryakiran PV; Folschweiller N; Thomas F; Lin L; Struyf F
Cancer Med; 2017 Nov; 6(11):2723-2731. PubMed ID: 28984053
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study.
Denny L; Hendricks B; Gordon C; Thomas F; Hezareh M; Dobbelaere K; Durand C; Hervé C; Descamps D
Vaccine; 2013 Nov; 31(48):5745-53. PubMed ID: 24091311
[TBL] [Abstract][Full Text] [Related]
10. Persistence of immune responses to the HPV-16/18 AS04-adjuvanted vaccine in women aged 15-55 years and first-time modelling of antibody responses in mature women: results from an open-label 6-year follow-up study.
Schwarz T; Spaczynski M; Kaufmann A; Wysocki J; Gałaj A; Schulze K; Suryakiran P; Thomas F; Descamps D
BJOG; 2015 Jan; 122(1):107-18. PubMed ID: 25208608
[TBL] [Abstract][Full Text] [Related]
11. Cervicovaginal Human Papillomavirus Genomes, Microbiota Composition and Cytokine Concentrations in South African Adolescents.
Happel AU; Balle C; Havyarimana E; Brown B; Maust BS; Feng C; Yi BH; Gill K; Bekker LG; Passmore JS; Jaspan HB; Varsani A
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992467
[TBL] [Abstract][Full Text] [Related]
12. Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model.
Gomez JA; Lepetic A; Demarteau N
BMC Public Health; 2014 Nov; 14():1222. PubMed ID: 25424716
[TBL] [Abstract][Full Text] [Related]
13. Association between the vaginal microbiome and high-risk human papillomavirus infection in pregnant Chinese women.
Chen Y; Hong Z; Wang W; Gu L; Gao H; Qiu L; Di W
BMC Infect Dis; 2019 Aug; 19(1):677. PubMed ID: 31370796
[TBL] [Abstract][Full Text] [Related]
14. Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12-15 years: end-of-study results from a community-randomized study up to 6.5 years.
Bi D; Apter D; Eriksson T; Hokkanen M; Zima J; Damaso S; Soila M; Dubin G; Lehtinen M; Struyf F
Hum Vaccin Immunother; 2020 Jun; 16(6):1392-1403. PubMed ID: 31829767
[TBL] [Abstract][Full Text] [Related]
15. Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 years.
Schwarz TF; Spaczynski M; Schneider A; Wysocki J; Galaj A; Schulze K; Poncelet SM; Catteau G; Thomas F; Descamps D
Hum Vaccin; 2011 Sep; 7(9):958-65. PubMed ID: 21892005
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Association Between Cervical Microbiota and HR-HPV Infection Based on 16S rRNA Gene and Metagenomic Sequencing.
Fang B; Li Q; Wan Z; OuYang Z; Zhang Q
Front Cell Infect Microbiol; 2022; 12():922554. PubMed ID: 35800388
[TBL] [Abstract][Full Text] [Related]
17. [Primary study on the relationship between high-risk HPV infection and vaginal cervical microbiota].
Zhang Z; Zhang D; Xiao BB; Zhang R; Bai HH; Dong HY; Bi H; Liu ZH
Zhonghua Fu Chan Ke Za Zhi; 2018 Jul; 53(7):471-480. PubMed ID: 30078257
[No Abstract] [Full Text] [Related]
18. Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota.
Shannon B; Yi TJ; Perusini S; Gajer P; Ma B; Humphrys MS; Thomas-Pavanel J; Chieza L; Janakiram P; Saunders M; Tharao W; Huibner S; Shahabi K; Ravel J; Rebbapragada A; Kaul R
Mucosal Immunol; 2017 Sep; 10(5):1310-1319. PubMed ID: 28120845
[TBL] [Abstract][Full Text] [Related]
19. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis.
Norenhag J; Du J; Olovsson M; Verstraelen H; Engstrand L; Brusselaers N
BJOG; 2020 Jan; 127(2):171-180. PubMed ID: 31237400
[TBL] [Abstract][Full Text] [Related]
20. Vaginal Microbiome Dysbiosis is Associated with the Different Cervical Disease Status.
Ma Y; Li Y; Liu Y; Cao L; Han X; Gao S; Zhang C
J Microbiol; 2023 Apr; 61(4):423-432. PubMed ID: 37010797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
